Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.
作者信息
McKenna W J, Harris L, Perez G, Krikler D M, Oakley C, Goodwin J F
出版信息
Br Heart J. 1981 Aug;46(2):173-8. doi: 10.1136/hrt.46.2.173.
Abstract
摘要
相似文献
1
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.肥厚型心肌病中的心律失常。II：胺碘酮与维拉帕米治疗效果比较
Br Heart J. 1981 Aug;46(2):173-8. doi: 10.1136/hrt.46.2.173.
2
Amiodarone and the cardiomyopathies.胺碘酮与心肌病
Br J Clin Pract Suppl. 1986 Apr;44:3-10.
3
[Amiodarone in ventricular arrhythmias of chronic Chagas cardiopathy].[胺碘酮用于慢性恰加斯病性心肌病的室性心律失常]
Arq Bras Cardiol. 1980 Aug;35(2):177-81.
4
Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
Am J Cardiol. 1984 Oct 1;54(7):802-10. doi: 10.1016/s0002-9149(84)80212-x.
5
Low-dose amiodarone for the treatment of arrhythmias in hypertrophic cardiomyopathy.小剂量胺碘酮治疗肥厚型心肌病心律失常
J Clin Pharmacol. 1989 May;29(5):436-8. doi: 10.1002/j.1552-4604.1989.tb03357.x.
6
[Clinical study of injectable amiodarone in arrhythmia].
Lille Med. 1976 Dec;21 Suppl 4:908-10.
7
[Amiodarone in subjects with pneumopathies].[胺碘酮在患有肺病的受试者中的应用]
Arch Monaldi. 1984 Jan-Apr;39(1-2):83-90.
8
[Clinical observation on 341 patients with arrhythmia treated with amiodarone].胺碘酮治疗341例心律失常患者的临床观察
Zhonghua Nei Ke Za Zhi. 1983 Nov;22(11):662-6.
9
Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms.维拉帕米、17-单氯乙酰阿马林、美西律和胺碘酮对重症恰加斯心肌病患者的抗心律失常疗效比较：与潜在致心律失常机制的关系
J Am Coll Cardiol. 1986 May;7(5):1114-20. doi: 10.1016/s0735-1097(86)80232-7.
10
[Therapy of arrhythmias in hypertrophic cardiomyopathy].
G Ital Cardiol. 1995 Nov;25(11):1443-6.
引用本文的文献
1
Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.非持续性室性心动过速在肥厚型心肌病中的预后价值及胺碘酮治疗的潜在作用：在未经选择的非转诊患者群体中的评估
Heart. 1998 Apr;79(4):331-6. doi: 10.1136/hrt.79.4.331.
2
Electrophysiological disturbances in heart failure.心力衰竭中的电生理紊乱。
Br Heart J. 1994 Aug;72(2 Suppl):S31-5. doi: 10.1136/hrt.72.2_suppl.s31.
3
Potential mechanisms of improvement after various treatments for hypertrophic obstructive cardiomyopathy.
Tex Heart Inst J. 1995;22(2):126-33.
4
Cardiac arrhythmias in hypertrophic cardiomyopathy.肥厚型心肌病中的心律失常
Br Heart J. 1982 Sep;48(3):198-203. doi: 10.1136/hrt.48.3.198.
5
Syncope in hypertrophic cardiomyopathy.肥厚型心肌病中的晕厥
Br Heart J. 1982 Feb;47(2):177-9. doi: 10.1136/hrt.47.2.177.
6
QT and action potential duration.QT间期与动作电位时程
Br Heart J. 1982 Jun;47(6):513-4. doi: 10.1136/hrt.47.6.513.
7
Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.
Eur J Clin Pharmacol. 1983;24(4):485-94. doi: 10.1007/BF00609891.
8
Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.肥厚性梗阻性心肌病。急性和慢性维拉帕米治疗对左心室收缩和舒张功能的影响。
Br Heart J. 1984 May;51(5):523-9. doi: 10.1136/hrt.51.5.523.
9
Amiodarone: the experience of the past decade.胺碘酮：过去十年的经验
Br Med J (Clin Res Ed). 1983 Dec 3;287(6406):1654-6. doi: 10.1136/bmj.287.6406.1654.
10
The frontiers of cardiomyopathy.心肌病的前沿领域。
Br Heart J. 1982 Jul;48(1):1-18. doi: 10.1136/hrt.48.1.1.
本文引用的文献
1
IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS. I. A DESCRIPTION OF THE DISEASE BASED UPON AN ANALYSIS OF 64 PATIENTS.特发性肥厚性主动脉瓣下狭窄。I. 基于对64例患者分析的疾病描述。
Circulation. 1964 Nov;30:SUPPL 4:3-119. doi: 10.1161/01.cir.29.5s4.iv-3.
2
Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.胺碘酮对阵发性顽固性心动过速患者的临床抗心律失常作用。
Br Heart J. 1980 Jul;44(1):91-5. doi: 10.1136/hrt.44.1.91.
3
Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.胺碘酮治疗顽固性室上性心律失常的电生理评估
Br Heart J. 1980 Jul;44(1):82-90. doi: 10.1136/hrt.44.1.82.
4
Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.肥厚型心肌病的预后：年龄及临床、心电图和血流动力学特征的作用
Am J Cardiol. 1981 Mar;47(3):532-8. doi: 10.1016/0002-9149(81)90535-x.
5
Prediction of mortality and serious ventricular arrhythmia in hypertrophic cardiomyopathy. An echocardiographic study.肥厚型心肌病患者死亡率及严重室性心律失常的预测：一项超声心动图研究
Br Heart J. 1980 Aug;44(2):150-7. doi: 10.1136/hrt.44.2.150.
6
M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction.
Am J Cardiol. 1980 Jan;45(1):6-14. doi: 10.1016/0002-9149(80)90213-1.
7
Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy.肥厚型心肌病中的心律失常：有无β肾上腺素能阻滞剂治疗时的运动及48小时动态心电图评估
Am J Cardiol. 1980 Jan;45(1):1-5. doi: 10.1016/0002-9149(80)90212-x.
8
Impaired rate of left ventricular filling in idiopathic hypertrophic subaortic stenosis and valvular aortic stenosis.
Circulation. 1968 Jan;37(1):8-14. doi: 10.1161/01.cir.37.1.8.
9
The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.一种新型抗心绞痛药物胺碘酮对心肌的作用。
Br J Pharmacol. 1970 Aug;39(4):657-67. doi: 10.1111/j.1476-5381.1970.tb09891.x.
10
Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation.冠心病患者的运动试验。评估原则及正常标准。
Ann Clin Res. 1971 Dec;3(6):323-32.
Zotero 插件